MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.

Type B

IMMEDIATE AND LONGER TERM IMMUNOGENICITY OF A SINGLE DOSE OF THE COMBINED HAEMOPHILUS INFLUENZAE TYPE B-NEISSERIA MENINGITIDIS SEROGROUP C-TETANUS TOXOID CONJUGATE VACCINE IN PRIMED TODDLERS 12 TO 18 MONTHS OF AGE

10.1097/inf.0b013e31820013d2 ◽

2011 ◽

Vol 30 (4) ◽

pp. 340-342 ◽

Cited By ~ 12

Author(s):

Robert Booy ◽

Peter Richmond ◽

Terry Nolan ◽

Jodie McVernon ◽

Helen Marshall ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B

Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C–Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers

10.1097/inf.0000000000000898 ◽

2015 ◽

Vol 34 (12) ◽

pp. 1379-1384 ◽

Cited By ~ 4

Author(s):

Robert Booy ◽

Terry Nolan ◽

Graham Reynolds ◽

Peter Richmond ◽

Michael Nissen ◽

...

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Antibody Persistence

IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN

The Lancet ◽

10.1016/s0140-6736(86)90001-2 ◽

1986 ◽

Vol 328 (8502) ◽

pp. 299-302 ◽

Cited By ~ 75

Author(s):

MenachemS Einhorn ◽

EdwinL Anderson ◽

GeoffreyA Weinberg ◽

PaulD Granoff ◽

DanM Granoff

Keyword(s):

Membrane Protein ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Outer Membrane ◽

Conjugate Vaccine ◽

Outer Membrane Protein ◽

Type B

Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide—Neisseria meningitidis outer membrane protein

Vaccine ◽

10.1016/0264-410x(91)90180-e ◽

1991 ◽

Vol 9 ◽

pp. S38-S41 ◽

Cited By ~ 8

Author(s):

V.I. Ahonkhai ◽

L.J. Lukacs ◽

L.C. Jonas ◽

G.B. Calandra

Keyword(s):

Membrane Protein ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Outer Membrane ◽

Conjugate Vaccine ◽

Clinical Experience ◽

Outer Membrane Protein ◽

Type B

Persistence of Antibody Responses to Haemophilus influenzae Type b Polysaccharide Conjugate Vaccine in Children with Vertically Acquired Human Immunodeficiency Virus Infection

10.1097/00006454-199612000-00008 ◽

1996 ◽

Vol 15 (12) ◽

pp. 1097-1101 ◽

Cited By ~ 31

Author(s):

DIANA GIBB ◽

ANTONIO GIACOMELLI ◽

JANET MASTERS ◽

VANA SPOULOU ◽

EZIA RUGA ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Virus Infection ◽

Human Immunodeficiency Virus Infection ◽

Haemophilus Influenzae ◽

Conjugate Vaccine ◽

Antibody Responses ◽

Type B ◽

Immunodeficiency Virus

Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine

10.1097/inf.0b013e318269433a ◽

2012 ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

Juan Carlos Tejedor ◽

José Manuel Merino ◽

Manuel Moro ◽

Maria-Luisa Navarro ◽

José Espín ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Booster Dose ◽

Type B ◽

Antibody Persistence

Faculty Opinions recommendation of Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962180.793465807 ◽

2012 ◽

Author(s):

Susan Coffin

Keyword(s):

Single Dose ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Antibody Persistence

Faculty Opinions recommendation of A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969130.793469931 ◽

2013 ◽

Author(s):

Susan Coffin

Keyword(s):

Hepatitis B ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Controlled Study ◽

Type B ◽

Randomized Controlled

The development of a new heptavalent diphtheria–tetanus–whole cell pertussis–hepatitis B–Haemophilus influenzae type b–Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2007.08.007 ◽

2008 ◽

Vol 12 (3) ◽

pp. 278-288 ◽

Cited By ~ 12

Author(s):

S. Gatchalian ◽

E. Palestroque ◽

I. De Vleeschauwer ◽

H.H. Han ◽

J. Poolman ◽

...

Keyword(s):

Hepatitis B ◽

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Type B ◽

Whole Cell ◽

Dose Ranging

Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12–15 Months of Age

10.1097/inf.0b013e3182840e35 ◽

2013 ◽

Vol 32 (6) ◽

pp. 662-668 ◽

Cited By ~ 8

Author(s):

Gary S. Marshall ◽

Mark Blatter ◽

Colin Marchant ◽

Emmanuel Aris ◽

Narcisa Mesaros ◽

...

Keyword(s):

Haemophilus Influenzae ◽

Neisseria Meningitidis ◽

Conjugate Vaccine ◽

Tetanus Toxoid ◽

Type B ◽

Antibody Persistence ◽

Fourth Dose